Are leading medical journals following their own policies on CONSORT reporting?

Contemporary Clinical Trials

Volumn 29, Issue 6, 2008, Pages 843-846

  Folkes, Amy ^a   Urquhart, Robin ^a   Grunfeld, Eva ^a,b  

^a Cancer Outcomes Research Program   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

CONSORT; Generalizability; Randomized controlled trial

Indexed keywords

ARTICLE; EVIDENCE BASED MEDICINE; INFORMATION PROCESSING; MEDICAL INFORMATION; MEDICAL LITERATURE; PEER REVIEW; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RELIABILITY;

CANADA; EDITORIAL POLICIES; EVIDENCE-BASED MEDICINE; HUMANS; MANUSCRIPTS AS TOPIC; NOVA SCOTIA; PERIODICALS AS TOPIC; PUBLICATIONS;

EID: 53849108440     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2008.07.004     Document Type: Article

References (19)

1. Begg C.B., Cho M.K., Eastwood S., Horton R., Moher D., Olkin I., et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276 8 (1996) 637-639.
2. Moher D., Schulz K., Altman D., and for the CONSORT Group. The consort statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 9263 (2001) 1191-1194
3. CONSORT. CONSORT endorsers: journals. Available at: http://www.consort-statement.org/index.aspx?o=1096. Accessed March 14, 2008.
4. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication. Available at: http://www.icmje.org/index.html#manuscript. Accessed March 14, 2008.
5. Moher D., Jones A., Lepage L., and for the CONSORT group. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 285 15 (2001) 1992-1995
6. Egger M., Juni P., Bartlett C., and for the CONSORT Group. Value of flow diagrams in reports of randomized controlled trials. JAMA 285 15 (2001) 1996-1999
7. Plint A.C., Moher A.D., Morrison A., Schulz K., Altman D.G., Hill C., et al. Does the CONSORT checklist improve the quality of reports of randomized controlled trials? A systematic review. MJA 185 5 (2006) 263-267
8. Hampton J. Presentation and analysis of the results of clinical trials in cardiovascular disease. BMJ 282 6273 (1981) 1371-1412
9. Wright J.R., Bouma S., Dayes I., Sussman J., Simunovic M.R., Levine M.N., et al. The importance of reporting patient recruitment details in phase III trials. J Clin Oncol 24 6 (2006) 843-845
10. Gross C.P., Mallory R., Heiat A., and Krumholz H.M. Reporting the recruitment process in clinical trials: who are these patients and how did they get there?. Ann Intern Med 137 1 (2002) 10-16
11. The Journal of the American Medical Association. Available at: http://jama.ama-assn.org. Accessed March 14, 2008.
12. The New England Journal of Medicine. Available at: http://content.nejm.org. Accessed March 14, 2008.
13. British Medical Journal. Available at: http://www.bmj.com. Accessed March 14, 2008.
14. The Lancet. Available at: http://www.thelancet.com/journals/lancet. Accessed March 14, 2008.
15. The New England Journal of Medicine. Authors centre help: FAQ about submissions. Available at: http://authors.nejm.org/Help/acHelp.asp. Accessed March 14, 2008.
16. Hopewell S., Altman D.G., Moher D., and Schulz K.F. Endorsement of the CONSORT statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors.'. Trials 9 20 (2008) 1-7
17. Horton R. CONSORT [Editor's reply]. Lancet 348 9029 (1996) 756-757
18. Sackett D., Haynes R., Guyatt G., and Tugwell P. Clinical Epidemiology. 2nd ed (1991), Little, Brown and Co., Toronto
19. Emanuel E., Schnipper L., Kamin D., Levinson W., and Lichter A. The costs of conducting clinical research. J Clin Oncol 21 22 (2003) 4145-4150